In his first address to a joint session of Congress April 28, President Joe Biden made a pitch for significantly increasing federal funding for biomedical research, especially cancer research—a cornerstone of his jobs plan.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
